Should diabetes be considered a coronary heart disease risk equivalent? Results from 25 years of follow-up in the Renfrew and Paisley Survey

被引:150
作者
Whiteley, L
Padmanabhan, S
Hole, D
Isles, C [1 ]
机构
[1] Dumfries & Galloway Royal Infirm, Med Unit, Dumfries DG1 4AP, Scotland
[2] Univ Glasgow, Dept Publ Hlth & Hlth Policy, Glasgow, Lanark, Scotland
关键词
D O I
10.2337/diacare.28.7.1588
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - The purpose of our study was to confirm or refute the view that diabetes be regarded as a coronary heart disease (CHD) risk equivalent and to test for sex differences in mortality. RESEARCH DESIGN AND METHODS - This was I prospective cohort study of 7,052 men and 8,354 women aged 45-64 years from Renfrew and Paisley, Scotland, who were first screened in 1972-1976 and followed for 25 years. All-cause mortality was calculated I,,; death per 1,000 person-years. A Cox proportional hazards model was used to adjust survival for age, smoking habit, blood pressure, serum cholesterol, BMI, and social class. RESULTS - There were 192 deaths in 228 subjects with diabetes and 2,010 deaths in 3,070 subjects with CHD. The highest mortality was in the group with both diabetes and CHD (100.2 deaths/1,000 person-years in men, 93.6 in women) and the lowest in the group with neither (29.2 deaths/1,000 person-years in men, 19.4 in women). Men and women with diabetes only and CHD only formed an intermediate risk group. The adjusted hazard ratio (HR) tor CHD mortality in men with diabetes only compared with men with CHD only was 1.17 (95% CI 0.78-1.74; P = 0.56). Corresponding HR for women was 1.97 (1.27-3.08 P = 0.003). CONCLUSIONS - Diabetes without previous CHD carries a lifetime risk of vascular death as high as that for CHD alone. Women may be at particular risk. Our data support the view that cardiovascular risk factors in diabetes should be treated as aggressively as in people with CHD.
引用
收藏
页码:1588 / 1593
页数:6
相关论文
共 27 条
[1]  
[Anonymous], 2002, JAMA
[2]  
[Anonymous], DIABETES CARE S1
[3]  
[Anonymous], 1997, LANCET
[4]  
Borch-Johnsen K, 1999, LANCET, V354, P617
[5]   VALIDATION OF QUESTIONNAIRE INFORMATION ON RISK-FACTORS AND DISEASE OUTCOMES IN A PROSPECTIVE COHORT STUDY OF WOMEN [J].
COLDITZ, GA ;
MARTIN, P ;
STAMPFER, MJ ;
WILLETT, WC ;
SAMPSON, L ;
ROSNER, B ;
HENNEKENS, CH ;
SPEIZER, FE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1986, 123 (05) :894-900
[6]   Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial [J].
Colhoun, HM ;
Betteridge, DJ ;
Durrington, PN ;
Hitman, GA ;
Neil, HAW ;
Livingstone, SJ ;
Thomason, MJ ;
Mackness, MI ;
Charlton-Menys, V ;
Fuller, JH .
LANCET, 2004, 364 (9435) :685-696
[7]  
Collins R, 2003, LANCET, V361, P2005
[8]   European guidelines on cardiovascular disease prevention in clinical practice -: Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice [J].
De Backer, G ;
Ambrosioni, E ;
Borch-Johnsen, K ;
Brotons, C ;
Cifkova, R ;
Dallongeville, J ;
Ebrahim, S ;
Faergeman, O ;
Graham, I ;
Mancia, G ;
Cats, VM ;
Orth-Gomér, K ;
Perk, J ;
Pyörälä, K ;
Rodicio, JL ;
Sans, S ;
Sansoy, V ;
Sechtem, U ;
Silber, S ;
Thomsen, T ;
Wood, D .
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2003, 10 (04) :S1-S10
[9]   Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality - The Multiple Risk Factor Intervention Trial experience [J].
Eberly, LE ;
Cohen, JD ;
Prineas, R ;
Yang, LF .
DIABETES CARE, 2003, 26 (03) :848-854
[10]   Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies [J].
Evans, JMM ;
Wang, JX ;
Morris, D .
BRITISH MEDICAL JOURNAL, 2002, 324 (7343) :939-942A